BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ponatinib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ponatinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

rebastinib
53 shared targets
bafetinib
28 shared targets
saracatinib
33 shared targets
nilotinib
38 shared targets
cep
29 shared targets
doramapimod
41 shared targets
tivozanib
27 shared targets
vandetanib
45 shared targets
golvatinib
27 shared targets
dasatinib
24 shared targets
Loading evidence profile...

This evidence profile for Ponatinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.